2020 Antibody Biology & Engineering Gordon Research Conference and Gordon Research Seminar

项目说明 本申请寻求对2020年戈登抗体生物学研究会议(GRC)的部分支持 和工程，以及将于3月15日举行的戈登研究研讨会(GRS)- 2020年20日，在美国加利福尼亚州文图拉海滩万豪酒店。这是关于这个主题的第6次GRC和第4rthGRS 代表了一次在社区中非常令人兴奋和有影响力的会议。这次会议的目的是 深入报道快速发展的抗体生物学领域的重要最新发展 和工程学，在一个旨在最大限度地讨论和互动的非正式环境中。这个领域有广阔的前景 对广泛的生物学和临床重要主题的影响，这些主题广泛跨越多个 生物医学领域，包括免疫、传染病、炎症和肿瘤学。 此外，在本系列会议中，我们将第四次纳入戈登研究研讨会(GRS)。 事实证明，这是戈登研究会议(GRC)的一个非常成功的补充。GRS将会 在GRC之前立即运行。它将专门为研究生提供研讨会和海报课程， 博士后研究员和早期职业科学家，允许他们介绍和讨论他们的研究。AS 在此之前，GRS主旨演讲者和GRC主席将通过 在GRS和GRS期间与受训人员进行指导会议和持续互动 随后的GRC会议。 GRC将主持约28-30位受邀演讲者的演讲，涵盖基础研究的主题 临床应用与来自学术界和工业界的科学家非常活跃的组合。据设想，一个 另外10-14个较短的演讲将主要由年轻科学家进行，他们是从提交的摘要中挑选出来的。在……里面 此外，GRC还将包括4个海报会议。 综上所述，2020 GRC将报告国际上最重要的最新研究进展 抗体生物学和工程学领域。这次会议展示的发现处于领先地位 治疗性抗体的研制及临床应用。建立在创意的悠久历史之上 本系列前三次会议的特点是学术界和产业界的互动，本GRC 及其相关的GRS将为学术和生物制药研究人员提供一个理想的机会 在世界各地建立网络并建立新的合作关系。我们设想新的治疗应用将是 很可能是由将在本次会议上提出的各种想法的交叉授粉产生的。此外，通过 为年轻的研究人员提供展示他们的研究并与更多人讨论他们的工作的机会 作为公认的科学家，这次会议将成为未来小组发展的重要跳板 在这一迅速崛起和至关重要的领域中的研究人员。 1|页码

Project Description This application seeks partial support for the 2020 Gordon Research Conference (GRC) on Antibody Biology and Engineering, together with an accompanying Gordon Research Seminar (GRS) to be held on March 15- 20, 2020 at the Ventura Beach Marriott, CA, USA. This is the 6th GRC and the 4rthGRS on this topic which is representative of a highly exciting and influential meeting in the community. The aim of this meeting is to provide in-depth coverage of important recent developments in the rapidly evolving field of antibody biology and engineering, in an informal setting designed for maximal discussion and interaction. This field has broad implications for a wide variety of biologic and clinically significant topics that cut broadly across the multiple fields within the biomedical community, including immunity, infectious diseases, inflammation and oncology. Furthermore, for the fourth time in this meeting series, we will incorporate a Gordon Research Seminar (GRS). This has proved to be a highly successful addition to the Gordon Research Conference (GRC). The GRS will run immediately prior to the GRC. It will provide seminar and poster sessions specifically for graduate students, post-doctoral fellows, and early career scientists to allow them to present and discuss their research. As before, a GRS keynote speaker together with the GRC chairs, will offer support and advice through a mentorship session and continuous interactions with the trainees during the course of the GRS and subsequent GRC meeting. The GRC will host approximately 28-30 talks from invited speakers, spanning topics in basic research through clinical applications with a very dynamic mix of scientists from academia and industry. It is envisioned, that an additional 10-14 shorter talks will be given primarily by young scientists, selected from submitted abstracts. In addition, the GRC will also incorporate 4 poster sessions. Taken together, the 2020 GRC will report the most significant recent research advances in an international field of antibody biology and engineering. The discoveries presented this conference are at the leading edge in the therapeutic antibody development and clinical applications. Building on the long history of creative academia-industry interactions which have characterized the three previous meetings in this series, this GRC and its associated GRS will provide an ideal opportunity for academic and bio-pharma researchers from around the world to network and forge new collaborations. We envision that novel therapeutic applications are likely to ensue from the cross pollination of the ideas that will be presented at this meeting. Furthermore, by providing opportunities for younger researchers to present their studies and to discuss their work with more established scientists, this meeting will act as an important spring board for the development of a future group of investigators in this rapidly emerging and critically important field. 1|Page